Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01618344 · ClinicalTrials.gov registry record
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 32
- Enrollment target
NCT01618344: Completed study, sponsored by University of Utah.
NCT01618344 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01618344 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.
Primary Outcome
Feasibility was assessed through participants' application usage and responses to self-reported questions about their use of the application. Acceptability was assessed through participants' perceived ease of use and perceived usefulness of the application.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-05 |
| Est. Completion | 2017-02 |
What the finished NCT01618344 record still lists
NCT01618344 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01618344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01618344 about?
NCT01618344 is a clinical study titled "Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer". To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.
What is the current status of trial NCT01618344?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2012-05. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT01618344?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia